BPG is committed to discovery and dissemination of knowledge
Citation
Sunakawa Y, Satake H, Ichikawa W. Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors. World J Gastrointest Oncol 2018; 10(12): 528-531 [PMID: 30595807 DOI: 10.4251/wjgo.v10.i12.528]
Please LOGIN to submit a new comment.